Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Other Operating Expenses (2017 - 2024)

Historic Other Operating Expenses for Dare Bioscience (DARE) over the last 5 years, with Q4 2024 value amounting to $92326.0.

  • Dare Bioscience's Other Operating Expenses rose 26930.4% to $92326.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $92326.0, marking a year-over-year increase of 18256.72%. This contributed to the annual value of $100000.0 for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2024, Dare Bioscience's Other Operating Expenses is $92326.0, which was up 26930.4% from $7674.0 recorded in Q1 2024.
  • Dare Bioscience's Other Operating Expenses' 5-year high stood at $92326.0 during Q4 2024, with a 5-year trough of $7674.0 in Q1 2024.
  • For the 4-year period, Dare Bioscience's Other Operating Expenses averaged around $29166.7, with its median value being $25000.0 (2021).
  • Data for Dare Bioscience's Other Operating Expenses shows a peak YoY increase of 26930.4% (in 2024) and a maximum YoY decrease of 6930.4% (in 2024) over the last 5 years.
  • Dare Bioscience's Other Operating Expenses (Quarter) stood at $25000.0 in 2021, then changed by 0.0% to $25000.0 in 2022, then changed by 0.0% to $25000.0 in 2023, then soared by 269.3% to $92326.0 in 2024.
  • Its last three reported values are $92326.0 in Q4 2024, $7674.0 for Q1 2024, and $25000.0 during Q4 2023.